Cipla Q3: Higher Costs Dent Margins

Feb 13 2014

February 13: Cipla stock was in focus in trade today. Market seems to have not liked the company’s Q3 performance. According to Cipla’s Q3 results, cost concerns seem to be escalating for the drug major. Agam Vakil shares a detailed report on the same.